nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—PTGS1—Dapsone—systemic lupus erythematosus	0.1	0.143	CbGbCtD
Candesartan—CYP2C8—Dapsone—systemic lupus erythematosus	0.0578	0.0827	CbGbCtD
Candesartan—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0566	0.0809	CbGbCtD
Candesartan—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0501	0.0717	CbGbCtD
Candesartan—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0448	0.064	CbGbCtD
Candesartan—CYP2C9—Dapsone—systemic lupus erythematosus	0.0403	0.0577	CbGbCtD
Candesartan—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.0402	0.0575	CbGbCtD
Candesartan—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.038	0.0543	CbGbCtD
Candesartan—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0339	0.0485	CbGbCtD
Candesartan—ABCB1—Betamethasone—systemic lupus erythematosus	0.0291	0.0416	CbGbCtD
Candesartan—ABCB1—Prednisolone—systemic lupus erythematosus	0.0287	0.0411	CbGbCtD
Candesartan—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0272	0.0389	CbGbCtD
Candesartan—ABCB1—Prednisone—systemic lupus erythematosus	0.0271	0.0388	CbGbCtD
Candesartan—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0265	0.0379	CbGbCtD
Candesartan—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0257	0.0368	CbGbCtD
Candesartan—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.025	0.0358	CbGbCtD
Candesartan—CYP2C9—cardial valve—systemic lupus erythematosus	0.0192	0.278	CbGeAlD
Candesartan—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0174	0.025	CbGbCtD
Candesartan—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0169	0.0242	CbGbCtD
Candesartan—ABCB1—Methotrexate—systemic lupus erythematosus	0.0136	0.0195	CbGbCtD
Candesartan—AGTR1—endothelium—systemic lupus erythematosus	0.00504	0.0732	CbGeAlD
Candesartan—AGTR1—blood plasma—systemic lupus erythematosus	0.00448	0.065	CbGeAlD
Candesartan—CYP2C9—urine—systemic lupus erythematosus	0.00413	0.06	CbGeAlD
Candesartan—CYP2C8—blood plasma—systemic lupus erythematosus	0.00243	0.0352	CbGeAlD
Candesartan—AGTR1—connective tissue—systemic lupus erythematosus	0.00238	0.0346	CbGeAlD
Candesartan—AGTR1—nephron tubule—systemic lupus erythematosus	0.00231	0.0335	CbGeAlD
Candesartan—PTGS1—endothelium—systemic lupus erythematosus	0.00222	0.0322	CbGeAlD
Candesartan—CYP2C9—blood plasma—systemic lupus erythematosus	0.00216	0.0313	CbGeAlD
Candesartan—AGTR1—kidney—systemic lupus erythematosus	0.00203	0.0294	CbGeAlD
Candesartan—AGTR1—cortex of kidney—systemic lupus erythematosus	0.00198	0.0287	CbGeAlD
Candesartan—PTGS1—blood plasma—systemic lupus erythematosus	0.00197	0.0286	CbGeAlD
Candesartan—Pranlukast—TNF—systemic lupus erythematosus	0.00186	0.359	CrCbGaD
Candesartan—AGTR1—lymphoid tissue—systemic lupus erythematosus	0.00174	0.0253	CbGeAlD
Candesartan—AGTR1—tendon—systemic lupus erythematosus	0.00164	0.0238	CbGeAlD
Candesartan—Telmisartan—PPARG—systemic lupus erythematosus	0.0016	0.309	CrCbGaD
Candesartan—AGTR1—lung—systemic lupus erythematosus	0.00144	0.0209	CbGeAlD
Candesartan—AGTR1—nervous system—systemic lupus erythematosus	0.00133	0.0193	CbGeAlD
Candesartan—AGTR1—central nervous system—systemic lupus erythematosus	0.00128	0.0186	CbGeAlD
Candesartan—ABCB1—blood plasma—systemic lupus erythematosus	0.00116	0.0169	CbGeAlD
Candesartan—CYP2C8—kidney—systemic lupus erythematosus	0.0011	0.016	CbGeAlD
Candesartan—PTGS1—connective tissue—systemic lupus erythematosus	0.00105	0.0152	CbGeAlD
Candesartan—PTGS1—skin of body—systemic lupus erythematosus	0.000946	0.0137	CbGeAlD
Candesartan—PTGS1—kidney—systemic lupus erythematosus	0.000892	0.0129	CbGeAlD
Candesartan—Losartan—ACE—systemic lupus erythematosus	0.000765	0.148	CrCbGaD
Candesartan—PTGS1—tendon—systemic lupus erythematosus	0.00072	0.0105	CbGeAlD
Candesartan—Valsartan—ALB—systemic lupus erythematosus	0.000641	0.124	CrCbGaD
Candesartan—PTGS1—lung—systemic lupus erythematosus	0.000632	0.00917	CbGeAlD
Candesartan—ABCB1—nephron tubule—systemic lupus erythematosus	0.0006	0.00871	CbGeAlD
Candesartan—PTGS1—nervous system—systemic lupus erythematosus	0.000585	0.0085	CbGeAlD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	0.000572	0.0162	CbGpPWpGaD
Candesartan—PTGS1—central nervous system—systemic lupus erythematosus	0.000564	0.00818	CbGeAlD
Candesartan—UGT1A3—Phase II conjugation—NAT2—systemic lupus erythematosus	0.000532	0.0151	CbGpPWpGaD
Candesartan—ABCB1—kidney—systemic lupus erythematosus	0.000528	0.00765	CbGeAlD
Candesartan—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000514	0.00746	CbGeAlD
Candesartan—ABCB1—Allograft Rejection—IL21—systemic lupus erythematosus	0.000497	0.0141	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL17A—systemic lupus erythematosus	0.000455	0.0129	CbGpPWpGaD
Candesartan—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000453	0.00657	CbGeAlD
Candesartan—AGTR1—ACE Inhibitor Pathway—TGFB1—systemic lupus erythematosus	0.000431	0.0122	CbGpPWpGaD
Candesartan—PTGS1—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	0.000424	0.012	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL12B—systemic lupus erythematosus	0.000423	0.012	CbGpPWpGaD
Candesartan—PTGS1—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.000418	0.0118	CbGpPWpGaD
Candesartan—ABCB1—bone marrow—systemic lupus erythematosus	0.000413	0.00599	CbGeAlD
Candesartan—AGTR1—Allograft Rejection—CXCL12—systemic lupus erythematosus	0.000408	0.0116	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—CD40—systemic lupus erythematosus	0.000404	0.0114	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—CTLA4—systemic lupus erythematosus	0.000398	0.0113	CbGpPWpGaD
Candesartan—ABCB1—lung—systemic lupus erythematosus	0.000374	0.00542	CbGeAlD
Candesartan—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—systemic lupus erythematosus	0.000363	0.0103	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	0.00035	0.00992	CbGpPWpGaD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—F2—systemic lupus erythematosus	0.000346	0.00981	CbGpPWpGaD
Candesartan—ABCB1—nervous system—systemic lupus erythematosus	0.000346	0.00502	CbGeAlD
Candesartan—ABCB1—central nervous system—systemic lupus erythematosus	0.000333	0.00484	CbGeAlD
Candesartan—AGTR1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	0.000328	0.00928	CbGpPWpGaD
Candesartan—ABCB1—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000319	0.00904	CbGpPWpGaD
Candesartan—Losartan—ALB—systemic lupus erythematosus	0.000313	0.0605	CrCbGaD
Candesartan—UGT1A3—Biological oxidations—NAT2—systemic lupus erythematosus	0.000311	0.00882	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL10—systemic lupus erythematosus	0.00031	0.00877	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—CD40LG—systemic lupus erythematosus	0.00031	0.00877	CbGpPWpGaD
Candesartan—UGT1A3—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000307	0.0087	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL4—systemic lupus erythematosus	0.000301	0.00853	CbGpPWpGaD
Candesartan—AGTR1—Peptide GPCRs—CCR5—systemic lupus erythematosus	0.000295	0.00835	CbGpPWpGaD
Candesartan—Dizziness—Azathioprine—systemic lupus erythematosus	0.000289	0.00151	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—FASLG—systemic lupus erythematosus	0.000288	0.00815	CbGpPWpGaD
Candesartan—Upper respiratory tract infection—Methotrexate—systemic lupus erythematosus	0.000288	0.0015	CcSEcCtD
Candesartan—Paraesthesia—Cyclosporine—systemic lupus erythematosus	0.000286	0.00149	CcSEcCtD
Candesartan—Cough—Triamcinolone—systemic lupus erythematosus	0.000285	0.00149	CcSEcCtD
Candesartan—PTGS1—Overview of nanoparticle effects—PTGS2—systemic lupus erythematosus	0.000285	0.00806	CbGpPWpGaD
Candesartan—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.000284	0.00148	CcSEcCtD
Candesartan—Somnolence—Cyclosporine—systemic lupus erythematosus	0.000283	0.00148	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000283	0.00148	CcSEcCtD
Candesartan—Tachycardia—Prednisolone—systemic lupus erythematosus	0.000283	0.00148	CcSEcCtD
Candesartan—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000282	0.00147	CcSEcCtD
Candesartan—Hypertension—Triamcinolone—systemic lupus erythematosus	0.000282	0.00147	CcSEcCtD
Candesartan—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.000281	0.00147	CcSEcCtD
Candesartan—Dyspepsia—Cyclosporine—systemic lupus erythematosus	0.00028	0.00146	CcSEcCtD
Candesartan—Hyperhidrosis—Prednisolone—systemic lupus erythematosus	0.00028	0.00146	CcSEcCtD
Candesartan—Paraesthesia—Mycophenolate mofetil—systemic lupus erythematosus	0.000279	0.00146	CcSEcCtD
Candesartan—Myalgia—Triamcinolone—systemic lupus erythematosus	0.000278	0.00145	CcSEcCtD
Candesartan—Vomiting—Azathioprine—systemic lupus erythematosus	0.000278	0.00145	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—FAS—systemic lupus erythematosus	0.000277	0.00786	CbGpPWpGaD
Candesartan—Myalgia—Methylprednisolone—systemic lupus erythematosus	0.000277	0.00145	CcSEcCtD
Candesartan—Arthralgia—Methylprednisolone—systemic lupus erythematosus	0.000277	0.00145	CcSEcCtD
Candesartan—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000277	0.00145	CcSEcCtD
Candesartan—Anxiety—Methylprednisolone—systemic lupus erythematosus	0.000276	0.00144	CcSEcCtD
Candesartan—Tachycardia—Hydrocortisone—systemic lupus erythematosus	0.000276	0.00144	CcSEcCtD
Candesartan—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	0.000276	0.00144	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IL2RA—systemic lupus erythematosus	0.000276	0.00781	CbGpPWpGaD
Candesartan—Rash—Azathioprine—systemic lupus erythematosus	0.000276	0.00144	CcSEcCtD
Candesartan—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000275	0.00144	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—systemic lupus erythematosus	0.000275	0.00779	CbGpPWpGaD
Candesartan—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000275	0.00144	CcSEcCtD
Candesartan—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000275	0.00143	CcSEcCtD
Candesartan—Headache—Azathioprine—systemic lupus erythematosus	0.000274	0.00143	CcSEcCtD
Candesartan—Hyperhidrosis—Hydrocortisone—systemic lupus erythematosus	0.000274	0.00143	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—C3—systemic lupus erythematosus	0.000274	0.00775	CbGpPWpGaD
Candesartan—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	0.000273	0.00143	CcSEcCtD
Candesartan—Dizziness—Leflunomide—systemic lupus erythematosus	0.000273	0.00143	CcSEcCtD
Candesartan—Renal failure—Methotrexate—systemic lupus erythematosus	0.000271	0.00142	CcSEcCtD
Candesartan—Angioedema—Betamethasone—systemic lupus erythematosus	0.000271	0.00141	CcSEcCtD
Candesartan—Angioedema—Dexamethasone—systemic lupus erythematosus	0.000271	0.00141	CcSEcCtD
Candesartan—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000268	0.0014	CcSEcCtD
Candesartan—Vertigo—Betamethasone—systemic lupus erythematosus	0.000266	0.00139	CcSEcCtD
Candesartan—Vertigo—Dexamethasone—systemic lupus erythematosus	0.000266	0.00139	CcSEcCtD
Candesartan—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.000264	0.00138	CcSEcCtD
Candesartan—Haematuria—Methotrexate—systemic lupus erythematosus	0.000263	0.00137	CcSEcCtD
Candesartan—Vomiting—Leflunomide—systemic lupus erythematosus	0.000262	0.00137	CcSEcCtD
Candesartan—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.00026	0.00136	CcSEcCtD
Candesartan—Epistaxis—Methotrexate—systemic lupus erythematosus	0.00026	0.00136	CcSEcCtD
Candesartan—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.00026	0.00136	CcSEcCtD
Candesartan—Rash—Leflunomide—systemic lupus erythematosus	0.00026	0.00136	CcSEcCtD
Candesartan—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.00026	0.00136	CcSEcCtD
Candesartan—Dermatitis—Leflunomide—systemic lupus erythematosus	0.00026	0.00136	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	0.00026	0.00736	CbGpPWpGaD
Candesartan—Mental disorder—Prednisone—systemic lupus erythematosus	0.00026	0.00136	CcSEcCtD
Candesartan—Nausea—Azathioprine—systemic lupus erythematosus	0.00026	0.00136	CcSEcCtD
Candesartan—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.00026	0.00136	CcSEcCtD
Candesartan—Headache—Leflunomide—systemic lupus erythematosus	0.000259	0.00135	CcSEcCtD
Candesartan—Malnutrition—Prednisone—systemic lupus erythematosus	0.000258	0.00135	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000258	0.00135	CcSEcCtD
Candesartan—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000258	0.00135	CcSEcCtD
Candesartan—Agranulocytosis—Methotrexate—systemic lupus erythematosus	0.000258	0.00134	CcSEcCtD
Candesartan—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000257	0.00134	CcSEcCtD
Candesartan—Hypertension—Betamethasone—systemic lupus erythematosus	0.000256	0.00134	CcSEcCtD
Candesartan—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000256	0.00134	CcSEcCtD
Candesartan—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000254	0.00133	CcSEcCtD
Candesartan—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000254	0.00133	CcSEcCtD
Candesartan—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000253	0.00132	CcSEcCtD
Candesartan—Myalgia—Betamethasone—systemic lupus erythematosus	0.000252	0.00132	CcSEcCtD
Candesartan—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000252	0.00132	CcSEcCtD
Candesartan—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000252	0.00131	CcSEcCtD
Candesartan—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000252	0.00131	CcSEcCtD
Candesartan—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000251	0.00131	CcSEcCtD
Candesartan—Anxiety—Betamethasone—systemic lupus erythematosus	0.000251	0.00131	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	0.000249	0.00706	CbGpPWpGaD
Candesartan—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000249	0.0013	CcSEcCtD
Candesartan—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000249	0.0013	CcSEcCtD
Candesartan—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000248	0.0013	CcSEcCtD
Candesartan—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000248	0.00129	CcSEcCtD
Candesartan—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000248	0.00129	CcSEcCtD
Candesartan—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000247	0.00129	CcSEcCtD
Candesartan—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000246	0.00128	CcSEcCtD
Candesartan—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000246	0.00128	CcSEcCtD
Candesartan—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000246	0.00128	CcSEcCtD
Candesartan—Nausea—Leflunomide—systemic lupus erythematosus	0.000245	0.00128	CcSEcCtD
Candesartan—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000245	0.00128	CcSEcCtD
Candesartan—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000244	0.00128	CcSEcCtD
Candesartan—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000244	0.00127	CcSEcCtD
Candesartan—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000243	0.00127	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000243	0.00127	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—C4A—systemic lupus erythematosus	0.000243	0.00687	CbGpPWpGaD
Candesartan—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000242	0.00127	CcSEcCtD
Candesartan—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000239	0.00125	CcSEcCtD
Candesartan—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000239	0.00125	CcSEcCtD
Candesartan—Anaemia—Prednisone—systemic lupus erythematosus	0.000238	0.00125	CcSEcCtD
Candesartan—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000238	0.00124	CcSEcCtD
Candesartan—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000237	0.00124	CcSEcCtD
Candesartan—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000237	0.00124	CcSEcCtD
Candesartan—PTGS1—Eicosanoid Synthesis—PTGS2—systemic lupus erythematosus	0.000236	0.00669	CbGpPWpGaD
Candesartan—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000236	0.00123	CcSEcCtD
Candesartan—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000236	0.00123	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	0.000236	0.00668	CbGpPWpGaD
Candesartan—Angioedema—Prednisone—systemic lupus erythematosus	0.000236	0.00123	CcSEcCtD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.000236	0.00667	CbGpPWpGaD
Candesartan—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000235	0.00123	CcSEcCtD
Candesartan—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000234	0.00122	CcSEcCtD
Candesartan—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000234	0.00122	CcSEcCtD
Candesartan—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000234	0.00122	CcSEcCtD
Candesartan—Vertigo—Prednisone—systemic lupus erythematosus	0.000232	0.00121	CcSEcCtD
Candesartan—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000231	0.00121	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	0.000231	0.00654	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—CD80—systemic lupus erythematosus	0.00023	0.00652	CbGpPWpGaD
Candesartan—Urticaria—Prednisolone—systemic lupus erythematosus	0.00023	0.0012	CcSEcCtD
Candesartan—Fatigue—Triamcinolone—systemic lupus erythematosus	0.00023	0.0012	CcSEcCtD
Candesartan—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000229	0.0012	CcSEcCtD
Candesartan—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000228	0.00119	CcSEcCtD
Candesartan—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000226	0.00118	CcSEcCtD
Candesartan—Hypotension—Betamethasone—systemic lupus erythematosus	0.000226	0.00118	CcSEcCtD
Candesartan—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000225	0.00118	CcSEcCtD
Candesartan—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000225	0.00117	CcSEcCtD
Candesartan—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000224	0.00117	CcSEcCtD
Candesartan—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000224	0.00117	CcSEcCtD
Candesartan—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000223	0.00116	CcSEcCtD
Candesartan—Hypertension—Prednisone—systemic lupus erythematosus	0.000223	0.00116	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.00022	0.00115	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.00022	0.00115	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—systemic lupus erythematosus	0.00022	0.00623	CbGpPWpGaD
Candesartan—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.00022	0.00115	CcSEcCtD
Candesartan—Arthralgia—Prednisone—systemic lupus erythematosus	0.00022	0.00115	CcSEcCtD
Candesartan—Myalgia—Prednisone—systemic lupus erythematosus	0.00022	0.00115	CcSEcCtD
Candesartan—Anxiety—Prednisone—systemic lupus erythematosus	0.000219	0.00114	CcSEcCtD
Candesartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—LYN—systemic lupus erythematosus	0.000218	0.00618	CbGpPWpGaD
Candesartan—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000218	0.00114	CcSEcCtD
Candesartan—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000217	0.00114	CcSEcCtD
Candesartan—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000217	0.00113	CcSEcCtD
Candesartan—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000217	0.00113	CcSEcCtD
Candesartan—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000217	0.00113	CcSEcCtD
Candesartan—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000216	0.00113	CcSEcCtD
Candesartan—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000213	0.00111	CcSEcCtD
Candesartan—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000213	0.00111	CcSEcCtD
Candesartan—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000213	0.00111	CcSEcCtD
Candesartan—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000212	0.00602	CbGpPWpGaD
Candesartan—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000212	0.00111	CcSEcCtD
Candesartan—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000211	0.0011	CcSEcCtD
Candesartan—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000211	0.0011	CcSEcCtD
Candesartan—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000211	0.0011	CcSEcCtD
Candesartan—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.00021	0.0011	CcSEcCtD
Candesartan—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000209	0.00109	CcSEcCtD
Candesartan—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000209	0.00109	CcSEcCtD
Candesartan—Back pain—Methotrexate—systemic lupus erythematosus	0.000209	0.00109	CcSEcCtD
Candesartan—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000208	0.00109	CcSEcCtD
Candesartan—Fatigue—Betamethasone—systemic lupus erythematosus	0.000208	0.00109	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	0.000207	0.00587	CbGpPWpGaD
Candesartan—Tachycardia—Prednisone—systemic lupus erythematosus	0.000206	0.00107	CcSEcCtD
Candesartan—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000205	0.00107	CcSEcCtD
Candesartan—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000204	0.00106	CcSEcCtD
Candesartan—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000203	0.00106	CcSEcCtD
Candesartan—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000202	0.00106	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	0.000202	0.00573	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.000202	0.00571	CbGpPWpGaD
Candesartan—Rash—Cyclosporine—systemic lupus erythematosus	0.000201	0.00105	CcSEcCtD
Candesartan—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000201	0.00105	CcSEcCtD
Candesartan—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.0002	0.00105	CcSEcCtD
Candesartan—Headache—Cyclosporine—systemic lupus erythematosus	0.0002	0.00104	CcSEcCtD
Candesartan—Anaemia—Methotrexate—systemic lupus erythematosus	0.000199	0.00104	CcSEcCtD
Candesartan—UGT1A3—NRF2 pathway—RXRA—systemic lupus erythematosus	0.000199	0.00564	CbGpPWpGaD
Candesartan—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000198	0.00562	CbGpPWpGaD
Candesartan—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000198	0.00103	CcSEcCtD
Candesartan—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000198	0.00103	CcSEcCtD
Candesartan—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000198	0.00103	CcSEcCtD
Candesartan—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	0.000197	0.00559	CbGpPWpGaD
Candesartan—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000196	0.00102	CcSEcCtD
Candesartan—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000196	0.00102	CcSEcCtD
Candesartan—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000195	0.00102	CcSEcCtD
Candesartan—Vertigo—Methotrexate—systemic lupus erythematosus	0.000194	0.00101	CcSEcCtD
Candesartan—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000194	0.00101	CcSEcCtD
Candesartan—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000193	0.00101	CcSEcCtD
Candesartan—PTGS1—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	0.000192	0.00544	CbGpPWpGaD
Candesartan—Urticaria—Betamethasone—systemic lupus erythematosus	0.000192	0.001	CcSEcCtD
Candesartan—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000192	0.001	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000192	0.001	CcSEcCtD
Candesartan—Dizziness—Prednisolone—systemic lupus erythematosus	0.000192	0.001	CcSEcCtD
Candesartan—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000191	0.000999	CcSEcCtD
Candesartan—AGTR1—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.000191	0.00541	CbGpPWpGaD
Candesartan—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000191	0.000998	CcSEcCtD
Candesartan—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000191	0.000998	CcSEcCtD
Candesartan—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000191	0.000998	CcSEcCtD
Candesartan—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000191	0.000998	CcSEcCtD
Candesartan—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000191	0.000996	CcSEcCtD
Candesartan—Nausea—Cyclosporine—systemic lupus erythematosus	0.000189	0.000988	CcSEcCtD
Candesartan—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000189	0.000988	CcSEcCtD
Candesartan—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000189	0.000985	CcSEcCtD
Candesartan—Cough—Methotrexate—systemic lupus erythematosus	0.000188	0.000983	CcSEcCtD
Candesartan—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000188	0.000983	CcSEcCtD
Candesartan—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000187	0.000977	CcSEcCtD
Candesartan—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000185	0.000968	CcSEcCtD
Candesartan—PTGS1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000185	0.00524	CbGpPWpGaD
Candesartan—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000185	0.000964	CcSEcCtD
Candesartan—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000184	0.000959	CcSEcCtD
Candesartan—Myalgia—Methotrexate—systemic lupus erythematosus	0.000184	0.000959	CcSEcCtD
Candesartan—Chest pain—Methotrexate—systemic lupus erythematosus	0.000184	0.000959	CcSEcCtD
Candesartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000183	0.00519	CbGpPWpGaD
Candesartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	0.000183	0.00518	CbGpPWpGaD
Candesartan—Rash—Prednisolone—systemic lupus erythematosus	0.000183	0.000954	CcSEcCtD
Candesartan—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000183	0.000953	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IFNG—systemic lupus erythematosus	0.000182	0.00515	CbGpPWpGaD
Candesartan—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000182	0.00095	CcSEcCtD
Candesartan—Fatigue—Prednisone—systemic lupus erythematosus	0.000182	0.000948	CcSEcCtD
Candesartan—Headache—Prednisolone—systemic lupus erythematosus	0.000182	0.000948	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	0.00018	0.0051	CbGpPWpGaD
Candesartan—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.00018	0.00094	CcSEcCtD
Candesartan—Rash—Hydrocortisone—systemic lupus erythematosus	0.000178	0.000932	CcSEcCtD
Candesartan—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000178	0.000931	CcSEcCtD
Candesartan—Headache—Hydrocortisone—systemic lupus erythematosus	0.000177	0.000926	CcSEcCtD
Candesartan—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000176	0.00092	CcSEcCtD
Candesartan—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000176	0.000918	CcSEcCtD
Candesartan—PTGS1—Biological oxidations—NAT2—systemic lupus erythematosus	0.000175	0.00497	CbGpPWpGaD
Candesartan—UGT1A3—Biological oxidations—RXRA—systemic lupus erythematosus	0.000175	0.00494	CbGpPWpGaD
Candesartan—Asthenia—Betamethasone—systemic lupus erythematosus	0.000173	0.000906	CcSEcCtD
Candesartan—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000173	0.000906	CcSEcCtD
Candesartan—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000172	0.0009	CcSEcCtD
Candesartan—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000172	0.000899	CcSEcCtD
Candesartan—Nausea—Prednisolone—systemic lupus erythematosus	0.000172	0.000899	CcSEcCtD
Candesartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000171	0.00485	CbGpPWpGaD
Candesartan—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000171	0.000894	CcSEcCtD
Candesartan—Pruritus—Betamethasone—systemic lupus erythematosus	0.000171	0.000894	CcSEcCtD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.000171	0.00484	CbGpPWpGaD
Candesartan—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.00017	0.000889	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—systemic lupus erythematosus	0.00017	0.00481	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—FOXP3—systemic lupus erythematosus	0.00017	0.00481	CbGpPWpGaD
Candesartan—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000169	0.000885	CcSEcCtD
Candesartan—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000169	0.000883	CcSEcCtD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000169	0.00478	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	0.000168	0.00476	CbGpPWpGaD
Candesartan—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000168	0.000878	CcSEcCtD
Candesartan—Rash—Triamcinolone—systemic lupus erythematosus	0.000168	0.000878	CcSEcCtD
Candesartan—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000168	0.000877	CcSEcCtD
Candesartan—Rash—Methylprednisolone—systemic lupus erythematosus	0.000168	0.000876	CcSEcCtD
Candesartan—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000168	0.000875	CcSEcCtD
Candesartan—Urticaria—Prednisone—systemic lupus erythematosus	0.000167	0.000874	CcSEcCtD
Candesartan—Headache—Triamcinolone—systemic lupus erythematosus	0.000167	0.000872	CcSEcCtD
Candesartan—Headache—Methylprednisolone—systemic lupus erythematosus	0.000167	0.00087	CcSEcCtD
Candesartan—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000166	0.000869	CcSEcCtD
Candesartan—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000166	0.000869	CcSEcCtD
Candesartan—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000165	0.000864	CcSEcCtD
Candesartan—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000165	0.000864	CcSEcCtD
Candesartan—Hypotension—Methotrexate—systemic lupus erythematosus	0.000164	0.000859	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IL2—systemic lupus erythematosus	0.000162	0.00458	CbGpPWpGaD
Candesartan—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.00016	0.000837	CcSEcCtD
Candesartan—Dizziness—Dexamethasone—systemic lupus erythematosus	0.00016	0.000835	CcSEcCtD
Candesartan—Dizziness—Betamethasone—systemic lupus erythematosus	0.00016	0.000835	CcSEcCtD
Candesartan—Nausea—Triamcinolone—systemic lupus erythematosus	0.000158	0.000827	CcSEcCtD
Candesartan—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000158	0.000825	CcSEcCtD
Candesartan—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000158	0.000825	CcSEcCtD
Candesartan—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000157	0.000819	CcSEcCtD
Candesartan—Somnolence—Methotrexate—systemic lupus erythematosus	0.000156	0.000817	CcSEcCtD
Candesartan—PTGS1—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	0.000155	0.00439	CbGpPWpGaD
Candesartan—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000155	0.000809	CcSEcCtD
Candesartan—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000154	0.000803	CcSEcCtD
Candesartan—Vomiting—Betamethasone—systemic lupus erythematosus	0.000154	0.000803	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000154	0.00435	CbGpPWpGaD
Candesartan—Rash—Dexamethasone—systemic lupus erythematosus	0.000152	0.000796	CcSEcCtD
Candesartan—Rash—Betamethasone—systemic lupus erythematosus	0.000152	0.000796	CcSEcCtD
Candesartan—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000152	0.000796	CcSEcCtD
Candesartan—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000152	0.000796	CcSEcCtD
Candesartan—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000152	0.000794	CcSEcCtD
Candesartan—Fatigue—Methotrexate—systemic lupus erythematosus	0.000152	0.000792	CcSEcCtD
Candesartan—Headache—Betamethasone—systemic lupus erythematosus	0.000151	0.000791	CcSEcCtD
Candesartan—Headache—Dexamethasone—systemic lupus erythematosus	0.000151	0.000791	CcSEcCtD
Candesartan—Asthenia—Prednisone—systemic lupus erythematosus	0.000151	0.000789	CcSEcCtD
Candesartan—Pruritus—Prednisone—systemic lupus erythematosus	0.000149	0.000778	CcSEcCtD
Candesartan—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000148	0.00418	CbGpPWpGaD
Candesartan—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000144	0.000753	CcSEcCtD
Candesartan—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000144	0.000752	CcSEcCtD
Candesartan—Nausea—Dexamethasone—systemic lupus erythematosus	0.000144	0.00075	CcSEcCtD
Candesartan—Nausea—Betamethasone—systemic lupus erythematosus	0.000144	0.00075	CcSEcCtD
Candesartan—Urticaria—Methotrexate—systemic lupus erythematosus	0.00014	0.00073	CcSEcCtD
Candesartan—Dizziness—Prednisone—systemic lupus erythematosus	0.000139	0.000727	CcSEcCtD
Candesartan—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000139	0.000727	CcSEcCtD
Candesartan—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000139	0.000727	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	0.000139	0.00393	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	0.000138	0.00392	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—VEGFA—systemic lupus erythematosus	0.000137	0.00389	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000136	0.00385	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	0.000136	0.00384	CbGpPWpGaD
Candesartan—Vomiting—Prednisone—systemic lupus erythematosus	0.000134	0.000699	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—IL17A—systemic lupus erythematosus	0.000134	0.00378	CbGpPWpGaD
Candesartan—Rash—Prednisone—systemic lupus erythematosus	0.000133	0.000693	CcSEcCtD
Candesartan—Dermatitis—Prednisone—systemic lupus erythematosus	0.000133	0.000693	CcSEcCtD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.000133	0.00376	CbGpPWpGaD
Candesartan—Headache—Prednisone—systemic lupus erythematosus	0.000132	0.000689	CcSEcCtD
Candesartan—PTGS1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	0.000131	0.00372	CbGpPWpGaD
Candesartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000128	0.00362	CbGpPWpGaD
Candesartan—Asthenia—Methotrexate—systemic lupus erythematosus	0.000126	0.000659	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—TGFB1—systemic lupus erythematosus	0.000126	0.00357	CbGpPWpGaD
Candesartan—Nausea—Prednisone—systemic lupus erythematosus	0.000125	0.000653	CcSEcCtD
Candesartan—Pruritus—Methotrexate—systemic lupus erythematosus	0.000125	0.00065	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	0.000125	0.00353	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL12B—systemic lupus erythematosus	0.000124	0.00352	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—F2—systemic lupus erythematosus	0.000121	0.00341	CbGpPWpGaD
Candesartan—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.00012	0.000629	CcSEcCtD
Candesartan—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.00012	0.0034	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CXCL12—systemic lupus erythematosus	0.00012	0.00339	CbGpPWpGaD
Candesartan—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.00012	0.00339	CbGpPWpGaD
Candesartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000119	0.00338	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	0.000119	0.00337	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	0.000119	0.00336	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—TNF—systemic lupus erythematosus	0.000118	0.00334	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	0.000117	0.00331	CbGpPWpGaD
Candesartan—Dizziness—Methotrexate—systemic lupus erythematosus	0.000116	0.000608	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—F2—systemic lupus erythematosus	0.000115	0.00325	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—NAT2—systemic lupus erythematosus	0.000113	0.00321	CbGpPWpGaD
Candesartan—Vomiting—Methotrexate—systemic lupus erythematosus	0.000112	0.000584	CcSEcCtD
Candesartan—CYP2C8—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000112	0.00316	CbGpPWpGaD
Candesartan—Rash—Methotrexate—systemic lupus erythematosus	0.000111	0.00058	CcSEcCtD
Candesartan—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000111	0.000579	CcSEcCtD
Candesartan—Headache—Methotrexate—systemic lupus erythematosus	0.00011	0.000576	CcSEcCtD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.000109	0.00308	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	0.000108	0.00305	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.000106	0.003	CbGpPWpGaD
Candesartan—Nausea—Methotrexate—systemic lupus erythematosus	0.000105	0.000546	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000103	0.00293	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	0.000103	0.00291	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	0.000102	0.0029	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—RXRA—systemic lupus erythematosus	9.83e-05	0.00278	CbGpPWpGaD
Candesartan—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	9.73e-05	0.00276	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	9.62e-05	0.00272	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	9.54e-05	0.0027	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	9.31e-05	0.00264	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	9.22e-05	0.00261	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	9.09e-05	0.00258	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	9.09e-05	0.00258	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	9.09e-05	0.00257	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	9.09e-05	0.00257	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	8.84e-05	0.0025	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	8.73e-05	0.00247	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	8.71e-05	0.00247	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	8.68e-05	0.00246	CbGpPWpGaD
Candesartan—CYP2C8—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	8.48e-05	0.0024	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	8.45e-05	0.00239	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	8.35e-05	0.00236	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	8.14e-05	0.00231	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	8.1e-05	0.00229	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	8.03e-05	0.00227	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	7.98e-05	0.00226	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	7.94e-05	0.00225	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	7.89e-05	0.00223	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	7.31e-05	0.00207	CbGpPWpGaD
Candesartan—UGT1A3—NRF2 pathway—TGFB1—systemic lupus erythematosus	7.15e-05	0.00202	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	7.12e-05	0.00202	CbGpPWpGaD
Candesartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	7.11e-05	0.00201	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCR5—systemic lupus erythematosus	7.09e-05	0.00201	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—C3—systemic lupus erythematosus	6.92e-05	0.00196	CbGpPWpGaD
Candesartan—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	6.9e-05	0.00195	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	6.76e-05	0.00191	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—RXRA—systemic lupus erythematosus	6.35e-05	0.0018	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	6.16e-05	0.00174	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—F2—systemic lupus erythematosus	6.08e-05	0.00172	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	5.84e-05	0.00165	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	5.81e-05	0.00164	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	5.64e-05	0.0016	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	5.45e-05	0.00154	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCL2—systemic lupus erythematosus	5.42e-05	0.00153	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	5.34e-05	0.00151	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—NAT2—systemic lupus erythematosus	5.33e-05	0.00151	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	5.31e-05	0.0015	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	5.17e-05	0.00146	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	5.09e-05	0.00144	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	4.95e-05	0.0014	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	4.92e-05	0.00139	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TLR9—systemic lupus erythematosus	4.81e-05	0.00136	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	4.75e-05	0.00134	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	4.66e-05	0.00132	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—P2RY12—systemic lupus erythematosus	4.66e-05	0.00132	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	4.55e-05	0.00129	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	4.4e-05	0.00125	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CSK—systemic lupus erythematosus	4.29e-05	0.00121	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	4.27e-05	0.00121	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	4.23e-05	0.0012	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	4.17e-05	0.00118	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	4.03e-05	0.00114	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	4.02e-05	0.00114	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	4e-05	0.00113	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	3.95e-05	0.00112	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NCF2—systemic lupus erythematosus	3.92e-05	0.00111	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—C3—systemic lupus erythematosus	3.91e-05	0.00111	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—LYN—systemic lupus erythematosus	3.89e-05	0.0011	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—JAK1—systemic lupus erythematosus	3.84e-05	0.00109	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.82e-05	0.00108	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.78e-05	0.00107	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	3.7e-05	0.00105	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCR5—systemic lupus erythematosus	3.64e-05	0.00103	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	3.58e-05	0.00101	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—C3—systemic lupus erythematosus	3.55e-05	0.00101	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	3.46e-05	0.000979	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—F2—systemic lupus erythematosus	3.44e-05	0.000973	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.13e-05	0.000888	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—F2—systemic lupus erythematosus	3.12e-05	0.000884	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—JUNB—systemic lupus erythematosus	3.08e-05	0.000871	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	3e-05	0.00085	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—RXRA—systemic lupus erythematosus	2.99e-05	0.000846	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.92e-05	0.000828	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PRL—systemic lupus erythematosus	2.83e-05	0.000803	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.78e-05	0.000788	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	2.53e-05	0.000716	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.53e-05	0.000715	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.44e-05	0.000691	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.39e-05	0.000678	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.38e-05	0.000675	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.31e-05	0.000655	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—JAK1—systemic lupus erythematosus	2.27e-05	0.000642	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.21e-05	0.000626	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCR5—systemic lupus erythematosus	2.15e-05	0.000608	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.14e-05	0.000607	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.12e-05	0.0006	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	2.1e-05	0.000595	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL2—systemic lupus erythematosus	2.1e-05	0.000595	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—C3—systemic lupus erythematosus	2.1e-05	0.000595	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.02e-05	0.000572	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.99e-05	0.000564	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.99e-05	0.000562	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	1.94e-05	0.000549	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPARG—systemic lupus erythematosus	1.89e-05	0.000534	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.88e-05	0.000531	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—F2—systemic lupus erythematosus	1.84e-05	0.000522	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.83e-05	0.000517	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CD80—systemic lupus erythematosus	1.77e-05	0.0005	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.71e-05	0.000483	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ALB—systemic lupus erythematosus	1.7e-05	0.00048	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	1.69e-05	0.000478	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	1.68e-05	0.000476	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.64e-05	0.000465	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—NOS3—systemic lupus erythematosus	1.62e-05	0.000459	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.58e-05	0.000447	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.56e-05	0.000442	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.54e-05	0.000436	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.49e-05	0.000422	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS2—systemic lupus erythematosus	1.48e-05	0.00042	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.46e-05	0.000415	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.38e-05	0.000392	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.27e-05	0.000359	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.25e-05	0.000355	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL2—systemic lupus erythematosus	1.24e-05	0.000352	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.24e-05	0.00035	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—EP300—systemic lupus erythematosus	1.23e-05	0.000349	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.21e-05	0.000343	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.17e-05	0.000333	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.17e-05	0.000331	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.15e-05	0.000325	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.13e-05	0.000319	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EP300—systemic lupus erythematosus	1.11e-05	0.000315	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	1.09e-05	0.000308	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	1.06e-05	0.000301	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.05e-05	0.000299	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.01e-05	0.000285	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	9.86e-06	0.000279	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.68e-06	0.000274	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALB—systemic lupus erythematosus	9.55e-06	0.00027	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	9.46e-06	0.000268	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	9.13e-06	0.000259	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	8.84e-06	0.00025	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	8.35e-06	0.000237	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.2e-06	0.000232	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—systemic lupus erythematosus	7.3e-06	0.000207	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—EP300—systemic lupus erythematosus	6.95e-06	0.000197	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	6.86e-06	0.000194	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	6.17e-06	0.000175	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	5.98e-06	0.000169	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	5.9e-06	0.000167	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	5.58e-06	0.000158	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	5.4e-06	0.000153	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALB—systemic lupus erythematosus	5.37e-06	0.000152	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	5.14e-06	0.000146	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	5.02e-06	0.000142	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	4.8e-06	0.000136	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	4.7e-06	0.000133	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	4.49e-06	0.000127	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	4.39e-06	0.000124	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—EP300—systemic lupus erythematosus	3.91e-06	0.000111	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	3.65e-06	0.000103	CbGpPWpGaD
